UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-22417
Destra Investment Trust |
(Exact name of registrant as specified in charter)
443 North Willson Avenue
Bozeman, MT 59715 |
(Address of principal executive offices) (Zip code)
Derek Mullins
443 North Willson Avenue
Bozeman, MT 59715 |
(Name and address of agent for service)
Registrant’s telephone number, including area code: (312)-843-6161
Date of fiscal year end: September 30
Date of reporting period: July 1, 2020 – June 30, 2021
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (§§ 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
PROXY VOTING RECORD
FOR PERIOD JULY 1, 2020 TO JUNE 30, 2021
Item 1: Proxy Voting Record
Registrant: Destra Investment Trust
Fund Name: Destra Flaherty & Crumrine Preferred and Income Fund
07/01/2020 - 06/30/2021
Issuer of Portfolio Security | Exchange Ticker Symbol | CUSIP # | Shareholder Meeting Date | Summary of Matter Voted On | Who Proposed Matter: Issuer / Shareholder | Whether Fund Cast Vote on Matter | Fund's Vote For or Against Proposal, or Abstain; For or Withhold Regarding Election of Directors | Whether Vote Was For or Against Management |
BARCLAYS PLC | BACR | 148104158 | 12/16/2020 | Upon a cessation event, the margin applicable to these securities remains unaltered | Issuer | Yes | For | For |
BARCLAYS PLC | BACR | 148104158 | 12/16/2020 | Upon cessation event, an adjustment is made to reflect the economic difference between a LIBOR linked mid-swap rate and UST rates | Issuer | Yes | For | For |
BARCLAYS PLC | BACR | 148104158 | 12/16/2020 | Upon occurrence of a cessation event in respect of 6 month USD LIBOR, replacing LIBOR linked mid-swap rate by an interest basis determined by reference to a UST rate | Issuer | Yes | For | For |
FIFTH THIRD BANCORP | FITB | 316773886 | 4/13/2021 | Annual vote on executive compensation plan | Issuer | Yes | For | For |
FIFTH THIRD BANCORP | FITB | 316773886 | 4/13/2021 | Approval of amendment to eliminate cumulative voting | Issuer | Yes | For | For |
FIFTH THIRD BANCORP | FITB | 316773886 | 4/13/2021 | Approval of amendment to eliminate statutory supermajority vote requirements | Issuer | Yes | For | For |
FIFTH THIRD BANCORP | FITB | 316773886 | 4/13/2021 | Approval of executive compensation plan | Issuer | Yes | For | For |
FIFTH THIRD BANCORP | FITB | 316773886 | 4/13/2021 | Approve 2021 incentive comp plan | Issuer | Yes | For | For |
FIFTH THIRD BANCORP | FITB | 316773886 | 4/13/2021 | Approve auditor | Issuer | Yes | For | For |
FIFTH THIRD BANCORP | FITB | 316773886 | 4/13/2021 | Approve directors | Issuer | Yes | For | For |
SIGNATURE BANK | SBNY | 82669G203 | 6/29/2021 | Approve amendment to 2004 Long-Term Incentive plan to increase the number of shares for issuance under the plan by 1.25 million shares | Issuer | Yes | For | For |
SIGNATURE BANK | SBNY | 82669G203 | 6/29/2021 | Approve the bank's $500 million stock repurchase plan | Issuer | Yes | For | For |
Registrant: Destra Investment Trust
Fund Name: Destra Granahan Small Cap Advantage Fund
07/01/2020 - 06/30/2021
Issuer of Portfolio Security | Exchange Ticker Symbol | CUSIP # | Shareholder Meeting Date | Summary of Matter Voted On | Who Proposed Matter: Issuer / Shareholder | Whether Fund Cast Vote on Matter | Fund's Vote For or Against Proposal, or Abstain; For or Withhold Regarding Election of Directors | Whether Vote Was For or Against Management |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Approve SPAC Transaction | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Increase Authorized Preferred and Common Stock | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Eliminate Class B Common Stock | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Approve No Class Vote on Changes in Authorized Number of Shares of Stock | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Amend Charter to Provide That Number of Directors Shall Be As Specified in Bylaws | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Amend Waiver of Corporate Opportunities Prospective Only | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Adopt Supermajority Vote Requirement for Amendments | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Approve Proposed Charter | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Elect Director Matt Ehrlichman | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Elect Director Joe Hanauer | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Elect Director Alan Pickerill | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Elect Director Asha Sharma | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Elect Director Chris Terrill | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Elect Director Javier Saade | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Elect Director Regi Vengalil | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Elect Director Thomas D. Hennessy | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Elect Director Margaret Whelan | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Issue Shares in Connection with Merger | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Approve Issuance of Shares for a Private Placement | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Approve Omnibus Stock Plan | Management | Yes | For | No |
PropTech Acquisition Corp. | PTAC | 74349F101 | 12/21/2020 | Adjourn Meeting | Management | Yes | For | No |
Liquidity Services, Inc. | LQDT | 53635B107 | 2/25/2021 | Elect Director Katharin S. Dyer | Management | Yes | For | No |
Liquidity Services, Inc. | LQDT | 53635B107 | 2/25/2021 | Elect Director Patrick W. Gross | Management | Yes | For | No |
Liquidity Services, Inc. | LQDT | 53635B107 | 2/25/2021 | Elect Director Beatriz V. Infante | Management | Yes | For | No |
Liquidity Services, Inc. | LQDT | 53635B107 | 2/25/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Liquidity Services, Inc. | LQDT | 53635B107 | 2/25/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Enanta Pharmaceuticals, Inc. | ENTA | 29251M106 | 3/2/2021 | Elect Director Kristine Peterson | Management | Yes | For | No |
Enanta Pharmaceuticals, Inc. | ENTA | 29251M106 | 3/2/2021 | Elect Director Terry C. Vance | Management | Yes | For | No |
Enanta Pharmaceuticals, Inc. | ENTA | 29251M106 | 3/2/2021 | Amend Omnibus Stock Plan | Management | Yes | For | No |
Enanta Pharmaceuticals, Inc. | ENTA | 29251M106 | 3/2/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Enanta Pharmaceuticals, Inc. | ENTA | 29251M106 | 3/2/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Increase Authorized Common Stock | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Approve SPAC Transaction | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Elect Director Rao Mulpuri | Management | Yes | Withhold | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Elect Director Tom Cheung | Management | Yes | Withhold | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Elect Director Nigel Gormly | Management | Yes | Withhold | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Elect Director Harold Hughes | Management | Yes | Withhold | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Elect Director Tom Leppert | Management | Yes | Withhold | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Elect Director Toby Cosgrove | Management | Yes | Withhold | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Elect Director Lisa Picard | Management | Yes | Withhold | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Approve Issuance of Shares for a Private Placement | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Approve Combination of Entity Class A Common Stock | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Change Company Name to View, Inc. | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Eliminate Preemptive Rights | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Approve Issuance and Selling of any Part or any Shares of Authorized Shares and Approve Company to Purchase any Shares of any Class of Authorized Shares | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Fix Number of Directors at Eleven | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Adopt Supermajority Vote Requirement to Amend Charter | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Adopt Supermajority Vote Requirement to Adopt, Amend, Repeal or Alter Bylaws | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Eliminate Blank Check Company Provisions | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Approve Omnibus Stock Plan | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Approve Stock Option Plan Grants | Management | Yes | Against | Yes |
CF Finance Acquisition Corp. II | CFII | 15725Q104 | 3/5/2021 | Adjourn Meeting | Management | Yes | Against | Yes |
Executive Network Partnering Corporation | ENPC | 30158L100 | 3/24/2021 | Approve Forward Stock Split and Amend Certain Terms of the Class B and Class F Common Stock | Management | Yes | For | No |
Executive Network Partnering Corporation | ENPC | 30158L100 | 3/24/2021 | Amend Warrant Agreement | Management | Yes | For | No |
Executive Network Partnering Corporation | ENPC | 30158L100 | 3/24/2021 | Adjourn Stockholder Meeting | Management | Yes | For | No |
Executive Network Partnering Corporation | ENPC | 30158L100 | 3/24/2021 | Adjourn Warrant Holder Meeting | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Receive Board's and Auditor's Reports | Management | Yes | No | |
Globant SA | GLOB | L44385109 | 4/2/2021 | Approve Consolidated Financial Statements and Statutory Reports | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Approve Financial Statements | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Approve Allocation of Loss | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Approve Discharge of Directors | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Approve Remuneration of Directors | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Appoint PricewaterhouseCoopers, Societe Cooperative as Auditor for Annual Accounts and EU IFRS Consolidated Accounts | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Appoint Price Waterhouse & Co. S.R.L. as Auditor for IFRS Consolidated Accounts | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Reelect Martin Migoya as Director | Management | Yes | Against | Yes |
Globant SA | GLOB | L44385109 | 4/2/2021 | Reelect Philip Odeen as Director | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Reelect Richard Haythornthwaite as Director | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Elect Maria Pinelli as Director | Management | Yes | For | No |
Globant SA | GLOB | L44385109 | 4/2/2021 | Approve Globant S.A. 2021 Employee Stock Purchase Plan | Management | Yes | For | No |
dMY Technology Group, Inc. II | DMYD | 233277102 | 4/16/2021 | Approve SPAC Transaction | Management | Yes | For | No |
dMY Technology Group, Inc. II | DMYD | 233277102 | 4/16/2021 | Adjourn Meeting | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director Robert S. Silberman | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director J. Kevin Gilligan | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director Robert R. Grusky | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director Charlotte F. Beason | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director Rita D. Brogley | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director John T. Casteen, III | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director H. James Dallas | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director Nathaniel C. Fick | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director Jerry L. Johnson | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director Karl McDonnell | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director William J. Slocum | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Elect Director G. Thomas Waite, III | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
Strategic Education, Inc. | STRA | 86272C103 | 4/27/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Douglas Dynamics, Inc. | PLOW | 25960R105 | 4/28/2021 | Elect Director Kenneth W. Krueger | Management | Yes | For | No |
Douglas Dynamics, Inc. | PLOW | 25960R105 | 4/28/2021 | Elect Director Lisa R. Bacus | Management | Yes | For | No |
Douglas Dynamics, Inc. | PLOW | 25960R105 | 4/28/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Douglas Dynamics, Inc. | PLOW | 25960R105 | 4/28/2021 | Ratify Deloitte & Touche LLP as Auditor | Management | Yes | For | No |
Vericel Corporation | VCEL | 92346J108 | 4/28/2021 | Elect Director Robert L. Zerbe | Management | Yes | For | No |
Vericel Corporation | VCEL | 92346J108 | 4/28/2021 | Elect Director Alan L. Rubino | Management | Yes | For | No |
Vericel Corporation | VCEL | 92346J108 | 4/28/2021 | Elect Director Heidi Hagen | Management | Yes | For | No |
Vericel Corporation | VCEL | 92346J108 | 4/28/2021 | Elect Director Steven C. Gilman | Management | Yes | For | No |
Vericel Corporation | VCEL | 92346J108 | 4/28/2021 | Elect Director Kevin F. McLaughlin | Management | Yes | For | No |
Vericel Corporation | VCEL | 92346J108 | 4/28/2021 | Elect Director Paul K. Wotton | Management | Yes | For | No |
Vericel Corporation | VCEL | 92346J108 | 4/28/2021 | Elect Director Dominick C. Colangelo | Management | Yes | For | No |
Vericel Corporation | VCEL | 92346J108 | 4/28/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Vericel Corporation | VCEL | 92346J108 | 4/28/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Elect Director Linda Baddour | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Elect Director Richard Berman | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Elect Director Daniel M. Hancock | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Elect Director Robert Hariri | Management | Yes | Withhold | Yes |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Elect Director Ram M. Jagannath | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Elect Director Ramkumar Mandalam | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Elect Director Jerrell W. Shelton | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Elect Director Edward J. Zecchini | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
CryoPort, Inc. | CYRX | 229050307 | 4/30/2021 | Amend Omnibus Stock Plan | Management | Yes | Against | Yes |
Paycom Software, Inc. | PAYC | 70432V102 | 5/3/2021 | Elect Director Robert J. Levenson | Management | Yes | Withhold | Yes |
Paycom Software, Inc. | PAYC | 70432V102 | 5/3/2021 | Elect Director Frederick C. Peters, II | Management | Yes | Withhold | Yes |
Paycom Software, Inc. | PAYC | 70432V102 | 5/3/2021 | Ratify Grant Thornton LLP as Auditors | Management | Yes | For | No |
Paycom Software, Inc. | PAYC | 70432V102 | 5/3/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | Against | Yes |
Paycom Software, Inc. | PAYC | 70432V102 | 5/3/2021 | Report on Plans to Improve Diversity of Executive Leadership | Share Holder | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Elect Director Vinod M. Khilnani | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Elect Director Emily M. Liggett | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Elect Director Robert J. Phillippy | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Elect Director Patrick Prevost | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Elect Director N. Mohan Reddy | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Elect Director Craig S. Shular | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Elect Director Darlene J. S. Solomon | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Elect Director Robert B. Toth | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Elect Director Jugal K. Vijayvargiya | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Materion Corporation | MTRN | 576690101 | 5/6/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Lawson Products, Inc. | LAWS | 520776105 | 5/11/2021 | Elect Director Andrew B. Albert | Management | Yes | For | No |
Lawson Products, Inc. | LAWS | 520776105 | 5/11/2021 | Elect Director I. Steven Edelson | Management | Yes | For | No |
Lawson Products, Inc. | LAWS | 520776105 | 5/11/2021 | Elect Director J. Bryan King | Management | Yes | For | No |
Lawson Products, Inc. | LAWS | 520776105 | 5/11/2021 | Elect Director Bianca A. Rhodes | Management | Yes | For | No |
Lawson Products, Inc. | LAWS | 520776105 | 5/11/2021 | Ratify BDO USA, LLP as Auditors | Management | Yes | For | No |
Lawson Products, Inc. | LAWS | 520776105 | 5/11/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Insmed Incorporated | INSM | 457669307 | 5/12/2021 | Elect Director David R. Brennan | Management | Yes | For | No |
Insmed Incorporated | INSM | 457669307 | 5/12/2021 | Elect Director Leo Lee | Management | Yes | For | No |
Insmed Incorporated | INSM | 457669307 | 5/12/2021 | Elect Director Carol A. Schafer | Management | Yes | For | No |
Insmed Incorporated | INSM | 457669307 | 5/12/2021 | Elect Director Melvin Sharoky | Management | Yes | For | No |
Insmed Incorporated | INSM | 457669307 | 5/12/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Insmed Incorporated | INSM | 457669307 | 5/12/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Insmed Incorporated | INSM | 457669307 | 5/12/2021 | Amend Omnibus Stock Plan | Management | Yes | For | No |
PROS Holdings, Inc. | PRO | 74346Y103 | 5/12/2021 | Elect Director Raja Hammoud | Management | Yes | For | No |
PROS Holdings, Inc. | PRO | 74346Y103 | 5/12/2021 | Elect Director William Russell | Management | Yes | For | No |
PROS Holdings, Inc. | PRO | 74346Y103 | 5/12/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
PROS Holdings, Inc. | PRO | 74346Y103 | 5/12/2021 | Amend Omnibus Stock Plan | Management | Yes | For | No |
PROS Holdings, Inc. | PRO | 74346Y103 | 5/12/2021 | Amend Qualified Employee Stock Purchase Plan | Management | Yes | For | No |
PROS Holdings, Inc. | PRO | 74346Y103 | 5/12/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
Chart Industries, Inc. | GTLS | 16115Q308 | 5/13/2021 | Elect Director Carey Chen | Management | Yes | For | No |
Chart Industries, Inc. | GTLS | 16115Q308 | 5/13/2021 | Elect Director Jillian C. Evanko | Management | Yes | For | No |
Chart Industries, Inc. | GTLS | 16115Q308 | 5/13/2021 | Elect Director Steven W. Krablin | Management | Yes | For | No |
Chart Industries, Inc. | GTLS | 16115Q308 | 5/13/2021 | Elect Director Singleton B. McAllister | Management | Yes | For | No |
Chart Industries, Inc. | GTLS | 16115Q308 | 5/13/2021 | Elect Director Michael L. Molinini | Management | Yes | For | No |
Chart Industries, Inc. | GTLS | 16115Q308 | 5/13/2021 | Elect Director David M. Sagehorn | Management | Yes | For | No |
Chart Industries, Inc. | GTLS | 16115Q308 | 5/13/2021 | Ratify Deloitte & Touche LLP as Auditor | Management | Yes | For | No |
Chart Industries, Inc. | GTLS | 16115Q308 | 5/13/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
MacroGenics, Inc. | MGNX | 556099109 | 5/13/2021 | Elect Director Kenneth Galbraith | Management | Yes | For | No |
MacroGenics, Inc. | MGNX | 556099109 | 5/13/2021 | Elect Director Scott Jackson | Management | Yes | For | No |
MacroGenics, Inc. | MGNX | 556099109 | 5/13/2021 | Elect Director David Stump | Management | Yes | For | No |
MacroGenics, Inc. | MGNX | 556099109 | 5/13/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
MacroGenics, Inc. | MGNX | 556099109 | 5/13/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Neoleukin Therapeutics, Inc. | NLTX | 64049K104 | 5/13/2021 | Elect Director Martin Babler | Management | Yes | For | No |
Neoleukin Therapeutics, Inc. | NLTX | 64049K104 | 5/13/2021 | Elect Director Erin Lavelle | Management | Yes | For | No |
Neoleukin Therapeutics, Inc. | NLTX | 64049K104 | 5/13/2021 | Elect Director Lewis T. "Rusty" Williams | Management | Yes | For | No |
Neoleukin Therapeutics, Inc. | NLTX | 64049K104 | 5/13/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
Neoleukin Therapeutics, Inc. | NLTX | 64049K104 | 5/13/2021 | Amend Omnibus Stock Plan | Management | Yes | Against | Yes |
Neoleukin Therapeutics, Inc. | NLTX | 64049K104 | 5/13/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Euronet Worldwide, Inc. | EEFT | 298736109 | 5/18/2021 | Elect Director Paul S. Althasen | Management | Yes | For | No |
Euronet Worldwide, Inc. | EEFT | 298736109 | 5/18/2021 | Elect Director Thomas A. McDonnell | Management | Yes | For | No |
Euronet Worldwide, Inc. | EEFT | 298736109 | 5/18/2021 | Elect Director Michael N. Frumkin | Management | Yes | For | No |
Euronet Worldwide, Inc. | EEFT | 298736109 | 5/18/2021 | Amend Omnibus Stock Plan | Management | Yes | For | No |
Euronet Worldwide, Inc. | EEFT | 298736109 | 5/18/2021 | Ratify KPMG LLP as Auditors | Management | Yes | For | No |
Euronet Worldwide, Inc. | EEFT | 298736109 | 5/18/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Harvard Bioscience, Inc. | HBIO | 416906105 | 5/18/2021 | Elect Director Alan Edrick | Management | Yes | For | No |
Harvard Bioscience, Inc. | HBIO | 416906105 | 5/18/2021 | Ratify Grant Thornton LLP as Auditors | Management | Yes | For | No |
Harvard Bioscience, Inc. | HBIO | 416906105 | 5/18/2021 | Approve Omnibus Stock Plan | Management | Yes | For | No |
Harvard Bioscience, Inc. | HBIO | 416906105 | 5/18/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Rush Enterprises, Inc. | RUSHA | 781846209 | 5/18/2021 | Elect Director W.M. "Rusty" Rush | Management | Yes | For | No |
Rush Enterprises, Inc. | RUSHA | 781846209 | 5/18/2021 | Elect Director Thomas A. Akin | Management | Yes | For | No |
Rush Enterprises, Inc. | RUSHA | 781846209 | 5/18/2021 | Elect Director James C. Underwood | Management | Yes | For | No |
Rush Enterprises, Inc. | RUSHA | 781846209 | 5/18/2021 | Elect Director Raymond J. Chess | Management | Yes | For | No |
Rush Enterprises, Inc. | RUSHA | 781846209 | 5/18/2021 | Elect Director William H. Cary | Management | Yes | For | No |
Rush Enterprises, Inc. | RUSHA | 781846209 | 5/18/2021 | Elect Director Kennon H. Guglielmo | Management | Yes | For | No |
Rush Enterprises, Inc. | RUSHA | 781846209 | 5/18/2021 | Elect Director Elaine Mendoza | Management | Yes | For | No |
Rush Enterprises, Inc. | RUSHA | 781846209 | 5/18/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Victory Capital Holdings, Inc. | VCTR | 92645B103 | 5/18/2021 | Elect Director Milton R. Berlinski | Management | Yes | Against | Yes |
Victory Capital Holdings, Inc. | VCTR | 92645B103 | 5/18/2021 | Elect Director David C. Brown | Management | Yes | Against | Yes |
Victory Capital Holdings, Inc. | VCTR | 92645B103 | 5/18/2021 | Elect Director Richard M. DeMartini | Management | Yes | Against | Yes |
Victory Capital Holdings, Inc. | VCTR | 92645B103 | 5/18/2021 | Ratify Ernst & Young LLP as Auditor | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director David Bronson | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director Brian P. Concannon | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director LaVerne Council | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director Charles M. Farkas | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director Martha Goldberg Aronson | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director Curt R. Hartman | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director Jerome J. Lande | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director Barbara J. Schwarzentraub | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director Mark E. Tryniski | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Elect Director John L. Workman | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
CONMED Corporation | CNMD | 207410101 | 5/19/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Enphase Energy, Inc. | ENPH | 29355A107 | 5/19/2021 | Elect Director Badrinarayanan Kothandaraman | Management | Yes | For | No |
Enphase Energy, Inc. | ENPH | 29355A107 | 5/19/2021 | Elect Director Joseph Malchow | Management | Yes | For | No |
Enphase Energy, Inc. | ENPH | 29355A107 | 5/19/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Enphase Energy, Inc. | ENPH | 29355A107 | 5/19/2021 | Increase Authorized Common Stock | Management | Yes | For | No |
Enphase Energy, Inc. | ENPH | 29355A107 | 5/19/2021 | Approve Omnibus Stock Plan | Management | Yes | For | No |
Enphase Energy, Inc. | ENPH | 29355A107 | 5/19/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
SPS Commerce, Inc. | SPSC | 78463M107 | 5/19/2021 | Elect Director Archie Black | Management | Yes | For | No |
SPS Commerce, Inc. | SPSC | 78463M107 | 5/19/2021 | Elect Director James Ramsey | Management | Yes | For | No |
SPS Commerce, Inc. | SPSC | 78463M107 | 5/19/2021 | Elect Director Marty Reaume | Management | Yes | For | No |
SPS Commerce, Inc. | SPSC | 78463M107 | 5/19/2021 | Elect Director Tami Reller | Management | Yes | For | No |
SPS Commerce, Inc. | SPSC | 78463M107 | 5/19/2021 | Elect Director Philip Soran | Management | Yes | For | No |
SPS Commerce, Inc. | SPSC | 78463M107 | 5/19/2021 | Elect Director Anne Sempowski Ward | Management | Yes | For | No |
SPS Commerce, Inc. | SPSC | 78463M107 | 5/19/2021 | Elect Director Sven Wehrwein | Management | Yes | For | No |
SPS Commerce, Inc. | SPSC | 78463M107 | 5/19/2021 | Ratify KPMG LLP as Auditors | Management | Yes | For | No |
SPS Commerce, Inc. | SPSC | 78463M107 | 5/19/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Elect Director Michael H. Carrel | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Elect Director Mark A. Collar | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Elect Director Daniel P. Florin | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Elect Director Regina E. Groves | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Elect Director B. Kristine Johnson | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Elect Director Karen N. Prange | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Elect Director Sven A. Wehrwein | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Elect Director Robert S. White | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
AtriCure, Inc. | ATRC | 04963C209 | 5/20/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
BioCryst Pharmaceuticals, Inc. | BCRX | 09058V103 | 5/25/2021 | Elect Director Nancy J. Hutson | Management | Yes | For | No |
BioCryst Pharmaceuticals, Inc. | BCRX | 09058V103 | 5/25/2021 | Elect Director Robert A. Ingram | Management | Yes | For | No |
BioCryst Pharmaceuticals, Inc. | BCRX | 09058V103 | 5/25/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
BioCryst Pharmaceuticals, Inc. | BCRX | 09058V103 | 5/25/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
BioCryst Pharmaceuticals, Inc. | BCRX | 09058V103 | 5/25/2021 | Amend Omnibus Stock Plan | Management | Yes | For | No |
BioCryst Pharmaceuticals, Inc. | BCRX | 09058V103 | 5/25/2021 | Amend Qualified Employee Stock Purchase Plan | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Elect Director Robert F. Carey | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Elect Director Kenneth J. Hillan | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Elect Director Alexander D. Macrae | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Elect Director John H. Markels | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Elect Director James R. Meyers | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Elect Director H. Stewart Parker | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Elect Director Saira Ramasastry | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Elect Director Karen L. Smith | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Elect Director Joseph S. Zakrzewski | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Approve Qualified Employee Stock Purchase Plan | Management | Yes | For | No |
Sangamo Therapeutics, Inc. | SGMO | 800677106 | 5/25/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
LivePerson, Inc. | LPSN | 538146101 | 5/26/2021 | Elect Director Kevin C. Lavan | Management | Yes | For | No |
LivePerson, Inc. | LPSN | 538146101 | 5/26/2021 | Elect Director Robert P. LoCascio | Management | Yes | For | No |
LivePerson, Inc. | LPSN | 538146101 | 5/26/2021 | Ratify BDO USA, LLP as Auditors | Management | Yes | For | No |
LivePerson, Inc. | LPSN | 538146101 | 5/26/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
LivePerson, Inc. | LPSN | 538146101 | 5/26/2021 | Amend Omnibus Stock Plan | Management | Yes | For | No |
Sprout Social, Inc. | SPT | 85209W109 | 5/26/2021 | Elect Director Justyn Howard | Management | Yes | Withhold | Yes |
Sprout Social, Inc. | SPT | 85209W109 | 5/26/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
Axon Enterprise, Inc. | AXON | 05464C101 | 5/27/2021 | Elect Director Richard H. Carmona | Management | Yes | For | No |
Axon Enterprise, Inc. | AXON | 05464C101 | 5/27/2021 | Elect Director Julie Cullivan | Management | Yes | For | No |
Axon Enterprise, Inc. | AXON | 05464C101 | 5/27/2021 | Elect Director Caitlin Kalinowski | Management | Yes | For | No |
Axon Enterprise, Inc. | AXON | 05464C101 | 5/27/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Axon Enterprise, Inc. | AXON | 05464C101 | 5/27/2021 | Ratify Grant Thornton LLP as Auditors | Management | Yes | For | No |
Axon Enterprise, Inc. | AXON | 05464C101 | 5/27/2021 | Approve the Increase in the Maximum Number of Directors from Nine to Eleven | Management | Yes | For | No |
Axon Enterprise, Inc. | AXON | 05464C101 | 5/27/2021 | Require a Majority Vote for the Election of Directors | Share Holder | Yes | Against | No |
Datto Holding Corp. | MSP | 23821D100 | 5/27/2021 | Elect Director David Breach | Management | Yes | Withhold | Yes |
Datto Holding Corp. | MSP | 23821D100 | 5/27/2021 | Elect Director Maneet S. Saroya | Management | Yes | Withhold | Yes |
Datto Holding Corp. | MSP | 23821D100 | 5/27/2021 | Elect Director John Stalder | Management | Yes | Withhold | Yes |
Datto Holding Corp. | MSP | 23821D100 | 5/27/2021 | Advisory Vote to Retain Classified Board Structure | Management | Yes | Against | Yes |
Datto Holding Corp. | MSP | 23821D100 | 5/27/2021 | Advisory Vote to Retain Supermajority Vote Requirement to Amend Certificate of Incorporation and Bylaws | Management | Yes | Against | Yes |
Datto Holding Corp. | MSP | 23821D100 | 5/27/2021 | Approve Qualified Employee Stock Purchase Plan | Management | Yes | For | No |
Datto Holding Corp. | MSP | 23821D100 | 5/27/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/27/2021 | Elect Director Jeffrey Berkowitz | Management | Yes | For | No |
Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/27/2021 | Elect Director Antonio M. Gotto, Jr. | Management | Yes | For | No |
Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/27/2021 | Elect Director Nicole Vitullo | Management | Yes | For | No |
Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/27/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/27/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Elect Director Douglas M. VanOort | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Elect Director Mark W. Mallon | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Elect Director Lynn A. Tetrault | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Elect Director Bruce K. Crowther | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Elect Director Alison L. Hannah | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Elect Director Kevin C. Johnson | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Elect Director Stephen M. Kanovsky | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Elect Director Michael A. Kelly | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Elect Director Rachel A. Stahler | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Amend Omnibus Stock Plan | Management | Yes | For | No |
NeoGenomics, Inc. | NEO | 64049M209 | 5/27/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
Blueprint Medicines Corporation | BPMC | 09627Y109 | 6/2/2021 | Elect Director George D. Demetri | Management | Yes | Withhold | Yes |
Blueprint Medicines Corporation | BPMC | 09627Y109 | 6/2/2021 | Elect Director Lynn Seely | Management | Yes | Withhold | Yes |
Blueprint Medicines Corporation | BPMC | 09627Y109 | 6/2/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Blueprint Medicines Corporation | BPMC | 09627Y109 | 6/2/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Chegg, Inc. | CHGG | 163092109 | 6/2/2021 | Elect Director Marne Levine | Management | Yes | For | No |
Chegg, Inc. | CHGG | 163092109 | 6/2/2021 | Elect Director Richard Sarnoff | Management | Yes | For | No |
Chegg, Inc. | CHGG | 163092109 | 6/2/2021 | Elect Director Paul LeBlanc | Management | Yes | For | No |
Chegg, Inc. | CHGG | 163092109 | 6/2/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Chegg, Inc. | CHGG | 163092109 | 6/2/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Elect Director Michael R. Klein | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Elect Director Andrew C. Florance | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Elect Director Laura Cox Kaplan | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Elect Director Michael J. Glosserman | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Elect Director John W. Hill | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Elect Director Robert W. Musslewhite | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Elect Director Christopher J. Nassetta | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Elect Director Louise S. Sams | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Increase Authorized Common Stock | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Amend Qualified Employee Stock Purchase Plan | Management | Yes | For | No |
CoStar Group, Inc. | CSGP | 22160N109 | 6/2/2021 | Eliminate Supermajority Vote Requirement | Share Holder | Yes | For | Yes |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Elect Director Joshua G. James | Management | Yes | Withhold | Yes |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Elect Director Carine S. Clark | Management | Yes | Withhold | Yes |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Elect Director Daniel Daniel | Management | Yes | Withhold | Yes |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Elect Director Joy Driscoll Durling | Management | Yes | Withhold | Yes |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Elect Director Dana Evan | Management | Yes | Withhold | Yes |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Elect Director Mark Gorenberg | Management | Yes | Withhold | Yes |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Elect Director Jeff Kearl | Management | Yes | Withhold | Yes |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | Against | Yes |
Domo, Inc. | DOMO | 257554105 | 6/2/2021 | Advisory Vote on Say on Pay Frequency | Management | Yes | One Year | No |
Turning Point Therapeutics, Inc. | TPTX | 90041T108 | 6/2/2021 | Elect Director Simeon J. George | Management | Yes | Withhold | Yes |
Turning Point Therapeutics, Inc. | TPTX | 90041T108 | 6/2/2021 | Elect Director Carol Gallagher | Management | Yes | Withhold | Yes |
Turning Point Therapeutics, Inc. | TPTX | 90041T108 | 6/2/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Turning Point Therapeutics, Inc. | TPTX | 90041T108 | 6/2/2021 | Advisory Vote on Say on Pay Frequency | Management | Yes | One Year | No |
Turning Point Therapeutics, Inc. | TPTX | 90041T108 | 6/2/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
2U, Inc. | TWOU | 90214J101 | 6/3/2021 | Elect Director Paul A. Maeder | Management | Yes | Withhold | Yes |
2U, Inc. | TWOU | 90214J101 | 6/3/2021 | Elect Director Christopher J. Paucek | Management | Yes | Withhold | Yes |
2U, Inc. | TWOU | 90214J101 | 6/3/2021 | Elect Director Gregory K. Peters | Management | Yes | Withhold | Yes |
2U, Inc. | TWOU | 90214J101 | 6/3/2021 | Elect Director Robert M. Stavis | Management | Yes | Withhold | Yes |
2U, Inc. | TWOU | 90214J101 | 6/3/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
2U, Inc. | TWOU | 90214J101 | 6/3/2021 | Ratify KPMG LLP as Auditors | Management | Yes | For | No |
2U, Inc. | TWOU | 90214J101 | 6/3/2021 | Declassify the Board of Directors | Share Holder | Yes | For | No |
Editas Medicine, Inc. | EDIT | 28106W103 | 6/3/2021 | Elect Director Meeta Chatterjee | Management | Yes | For | No |
Editas Medicine, Inc. | EDIT | 28106W103 | 6/3/2021 | Elect Director Andrew Hirsch | Management | Yes | Withhold | Yes |
Editas Medicine, Inc. | EDIT | 28106W103 | 6/3/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Editas Medicine, Inc. | EDIT | 28106W103 | 6/3/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Workiva Inc. | WK | 98139A105 | 6/3/2021 | Elect Director Robert H. Herz | Management | Yes | Withhold | Yes |
Workiva Inc. | WK | 98139A105 | 6/3/2021 | Elect Director David S. Mulcahy | Management | Yes | Withhold | Yes |
Workiva Inc. | WK | 98139A105 | 6/3/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Workiva Inc. | WK | 98139A105 | 6/3/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Innovative Industrial Properties, Inc. | IIPR | 45781V101 | 6/4/2021 | Elect Director Alan Gold | Management | Yes | For | No |
Innovative Industrial Properties, Inc. | IIPR | 45781V101 | 6/4/2021 | Elect Director Gary Kreitzer | Management | Yes | For | No |
Innovative Industrial Properties, Inc. | IIPR | 45781V101 | 6/4/2021 | Elect Director Mary Curran | Management | Yes | For | No |
Innovative Industrial Properties, Inc. | IIPR | 45781V101 | 6/4/2021 | Elect Director Scott Shoemaker | Management | Yes | For | No |
Innovative Industrial Properties, Inc. | IIPR | 45781V101 | 6/4/2021 | Elect Director Paul Smithers | Management | Yes | For | No |
Innovative Industrial Properties, Inc. | IIPR | 45781V101 | 6/4/2021 | Elect Director David Stecher | Management | Yes | For | No |
Innovative Industrial Properties, Inc. | IIPR | 45781V101 | 6/4/2021 | Ratify BDO USA, LLP as Auditors | Management | Yes | For | No |
Innovative Industrial Properties, Inc. | IIPR | 45781V101 | 6/4/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
The Lovesac Company | LOVE | 54738L109 | 6/7/2021 | Elect Director Mary Fox | Management | Yes | Withhold | Yes |
The Lovesac Company | LOVE | 54738L109 | 6/7/2021 | Elect Director John Grafer | Management | Yes | Withhold | Yes |
The Lovesac Company | LOVE | 54738L109 | 6/7/2021 | Elect Director Andrew R. Heyer | Management | Yes | Withhold | Yes |
The Lovesac Company | LOVE | 54738L109 | 6/7/2021 | Elect Director Sharon M. Leite | Management | Yes | For | No |
The Lovesac Company | LOVE | 54738L109 | 6/7/2021 | Elect Director Walter D. McLallen | Management | Yes | Withhold | Yes |
The Lovesac Company | LOVE | 54738L109 | 6/7/2021 | Elect Director Shawn Nelson | Management | Yes | Withhold | Yes |
The Lovesac Company | LOVE | 54738L109 | 6/7/2021 | Elect Director Shirley Romig | Management | Yes | Withhold | Yes |
The Lovesac Company | LOVE | 54738L109 | 6/7/2021 | Approve Increase in Size of Board | Management | Yes | For | No |
The Lovesac Company | LOVE | 54738L109 | 6/7/2021 | Ratify Marcum LLP as Auditors | Management | Yes | For | No |
Titan Machinery Inc. | TITN | 88830R101 | 6/7/2021 | Elect Director Stan Erickson | Management | Yes | For | No |
Titan Machinery Inc. | TITN | 88830R101 | 6/7/2021 | Elect Director Jody Horner | Management | Yes | For | No |
Titan Machinery Inc. | TITN | 88830R101 | 6/7/2021 | Elect Director Richard Mack | Management | Yes | For | No |
Titan Machinery Inc. | TITN | 88830R101 | 6/7/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Titan Machinery Inc. | TITN | 88830R101 | 6/7/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
Veracyte, Inc. | VCYT | 92337F107 | 6/7/2021 | Elect Director Muna Bhanji | Management | Yes | For | No |
Veracyte, Inc. | VCYT | 92337F107 | 6/7/2021 | Elect Director John L. Bishop | Management | Yes | For | No |
Veracyte, Inc. | VCYT | 92337F107 | 6/7/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Veracyte, Inc. | VCYT | 92337F107 | 6/7/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Nancy Altobello | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Felicia Alvaro | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Robert Cavanaugh | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Dean Carter | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Richard Haddrill | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Adam L. Miller | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Joseph Osnoss | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Philip S. Saunders | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Steffan C. Tomlinson | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Elect Director Sara Martinez Tucker | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Cornerstone OnDemand, Inc. | CSOD | 21925Y103 | 6/8/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
Alta Equipment Group, Inc. | ALTG | 02128L106 | 6/9/2021 | Elect Director Daniel Shribman | Management | Yes | Withhold | Yes |
Alta Equipment Group, Inc. | ALTG | 02128L106 | 6/9/2021 | Elect Director Katherine E. White | Management | Yes | Withhold | Yes |
Alta Equipment Group, Inc. | ALTG | 02128L106 | 6/9/2021 | Ratify UHY LLP as Auditors | Management | Yes | For | No |
Beam Therapeutics, Inc. | BEAM | 07373V105 | 6/9/2021 | Elect Director Kristina Burow | Management | Yes | Against | Yes |
Beam Therapeutics, Inc. | BEAM | 07373V105 | 6/9/2021 | Elect Director Graham Cooper | Management | Yes | Against | Yes |
Beam Therapeutics, Inc. | BEAM | 07373V105 | 6/9/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Elect Director Alok Maskara | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Elect Director David Landless | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Elect Director Clive Snowdon | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Elect Director Richard Hipple | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Elect Director Allisha Elliott | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Elect Director Lisa Trimberger | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Approve Remuneration Policy | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Approve Remuneration Report | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Advisory Vote on Say on Pay Frequency | Management | Yes | One Year | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
Luxfer Holdings Plc | LXFR | G5698W116 | 6/9/2021 | Authorize Audit Committee to Fix Remuneration of Auditors | Management | Yes | For | No |
OneSpaWorld Holdings Limited | OSW | P73684113 | 6/9/2021 | Elect Director Marc Magliacano | Management | Yes | Withhold | Yes |
OneSpaWorld Holdings Limited | OSW | P73684113 | 6/9/2021 | Elect Director Jeffrey E. Stiefler | Management | Yes | Withhold | Yes |
OneSpaWorld Holdings Limited | OSW | P73684113 | 6/9/2021 | Elect Director Walter F. McLallen | Management | Yes | Withhold | Yes |
OneSpaWorld Holdings Limited | OSW | P73684113 | 6/9/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Paratek Pharmaceuticals, Inc. | PRTK | 699374302 | 6/9/2021 | Elect Director Rolf K. Hoffmann | Management | Yes | For | No |
Paratek Pharmaceuticals, Inc. | PRTK | 699374302 | 6/9/2021 | Elect Director Kristine Peterson | Management | Yes | For | No |
Paratek Pharmaceuticals, Inc. | PRTK | 699374302 | 6/9/2021 | Elect Director Jeffrey Stein | Management | Yes | For | No |
Paratek Pharmaceuticals, Inc. | PRTK | 699374302 | 6/9/2021 | Increase Authorized Common Stock | Management | Yes | For | No |
Paratek Pharmaceuticals, Inc. | PRTK | 699374302 | 6/9/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Porch Group, Inc. | PRCH | 733245104 | 6/9/2021 | Elect Director Javier Saade | Management | Yes | For | No |
Porch Group, Inc. | PRCH | 733245104 | 6/9/2021 | Elect Director Chris Terrill | Management | Yes | For | No |
Porch Group, Inc. | PRCH | 733245104 | 6/9/2021 | Elect Director Margaret Whelan | Management | Yes | For | No |
Porch Group, Inc. | PRCH | 733245104 | 6/9/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Castle Biosciences, Inc. | CSTL | 14843C105 | 6/10/2021 | Elect Director Mara G. Aspinall | Management | Yes | Withhold | Yes |
Castle Biosciences, Inc. | CSTL | 14843C105 | 6/10/2021 | Elect Director Daniel M. Bradbury | Management | Yes | Withhold | Yes |
Castle Biosciences, Inc. | CSTL | 14843C105 | 6/10/2021 | Ratify KPMG LLP as Auditors | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Accept Consolidated Financial Statements and Statutory Reports | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve Treatment of Net Loss | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve Discharge of Board and Senior Management | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Director Rodger Novak | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Director Samarth Kulkarni | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Director Ali Behbahani | Management | Yes | Against | Yes |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Director Bradley Bolzon | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Director Simeon J. George | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Director John T. Greene | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Director Katherine A. High | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Director Douglas A. Treco | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Elect Director H Edward Fleming, Jr. | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Ali Behbahani as Member of the Compensation Committee | Management | Yes | Against | Yes |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect Simeon J. George as Member of the Compensation Committee | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Reelect John T. Greene as Member of the Compensation Committee | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve Remuneration of Directors in the Amount of USD 507,000 | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve Remuneration of Directors in the Amount of USD 11,738,100 | Management | Yes | Against | Yes |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve Remuneration of Executive Committee in the Amount of USD 3,514,207 | Management | Yes | Against | Yes |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve Remuneration of Executive Committee in the Amount of USD 2,693,933 | Management | Yes | Against | Yes |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve Remuneration of Executive Committee in the Amount of USD 55,827,593 | Management | Yes | Against | Yes |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve Increase in Conditional Share Capital for Employee Equity Plans | Management | Yes | Against | Yes |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve Increase in Size of Board | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Approve CHF 1,179,509 Increase in Authorized Capital | Management | Yes | Against | Yes |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Designate Marius Meier as Independent Proxy | Management | Yes | For | No |
CRISPR Therapeutics AG | CRSP | H17182108 | 6/10/2021 | Ratify Ernst & Young LLP as Auditor and Ernst & Young AG as Statutory Auditor | Management | Yes | For | No |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Elect Director Darryl Auguste | Management | Yes | Withhold | Yes |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Elect Director David Blundin | Management | Yes | Withhold | Yes |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Elect Director Sanju Bansal | Management | Yes | Withhold | Yes |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Elect Director Paul Deninger | Management | Yes | Withhold | Yes |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Elect Director John Lunny | Management | Yes | Withhold | Yes |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Elect Director Jayme Mendal | Management | Yes | Withhold | Yes |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Elect Director George Neble | Management | Yes | Withhold | Yes |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Elect Director John Shields | Management | Yes | Withhold | Yes |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Elect Director Mira Wilczek | Management | Yes | Withhold | Yes |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
EverQuote, Inc. | EVER | 30041R108 | 6/10/2021 | Advisory Vote on Say on Pay Frequency | Management | Yes | One Year | Yes |
Evolent Health, Inc. | EVH | 30050B101 | 6/10/2021 | Declassify the Board of Directors | Management | Yes | For | No |
Evolent Health, Inc. | EVH | 30050B101 | 6/10/2021 | Eliminate Supermajority Vote Requirements | Management | Yes | For | No |
Evolent Health, Inc. | EVH | 30050B101 | 6/10/2021 | Elect Director Craig Barbarosh | Management | Yes | For | No |
Evolent Health, Inc. | EVH | 30050B101 | 6/10/2021 | Elect Director Kim Keck | Management | Yes | For | No |
Evolent Health, Inc. | EVH | 30050B101 | 6/10/2021 | Elect Director Cheryl Scott | Management | Yes | For | No |
Evolent Health, Inc. | EVH | 30050B101 | 6/10/2021 | Elect Director Frank Williams | Management | Yes | For | No |
Evolent Health, Inc. | EVH | 30050B101 | 6/10/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
Evolent Health, Inc. | EVH | 30050B101 | 6/10/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Evolent Health, Inc. | EVH | 30050B101 | 6/10/2021 | Amend Omnibus Stock Plan | Management | Yes | For | No |
Etsy, Inc. | ETSY | 29786A106 | 6/11/2021 | Elect Director Gary S. Briggs | Management | Yes | For | No |
Etsy, Inc. | ETSY | 29786A106 | 6/11/2021 | Elect Director Edith W. Cooper | Management | Yes | For | No |
Etsy, Inc. | ETSY | 29786A106 | 6/11/2021 | Elect Director Melissa Reiff | Management | Yes | For | No |
Etsy, Inc. | ETSY | 29786A106 | 6/11/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
Etsy, Inc. | ETSY | 29786A106 | 6/11/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Lizabeth Ardisana | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Philippe Charleux | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Andrew J. Littlefair | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Thomas Maurisse | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director James C. Miller, III | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Stephen A. Scully | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Kenneth M. Socha | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Vincent C. Taormina | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Parker A. Weil | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Ratify KPMG LLP as Auditors | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Approve Issuance of Common Stock Upon Exercise Amazon Warrant | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Increase Authorized Common Stock | Management | No | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Lizabeth Ardisana | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Philippe Charleux | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Andrew J. Littlefair | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Thomas Maurisse | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director James C. Miller, III | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Stephen A. Scully | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Kenneth M. Socha | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Vincent C. Taormina | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Elect Director Parker A. Weil | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Ratify KPMG LLP as Auditors | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Approve Issuance of Common Stock Upon Exercise Amazon Warrant | Management | Yes | For | No |
Clean Energy Fuels Corp. | CLNE | 184499101 | 6/14/2021 | Increase Authorized Common Stock | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Open Meeting | Management | Yes | No | |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Receive Report of Management Board (Non-Voting) | Management | Yes | No | |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Adopt Financial Statements and Statutory Reports | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Approve Discharge of Management Board | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Approve Discharge of Supervisory Board | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Elect Denise Mueller to Management Board | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Reelect Ulrich Grau to Supervisory Board | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Reelect Mathieu Simon to Supervisory Board | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Elect Uta Kemmerich-Keil to Supervisory Board | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Ratify KPMG N.V. as Auditors | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Authorize Repurchase of Shares | Management | Yes | For | No |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Other Business (Non-Voting) | Management | Yes | No | |
Affimed NV | AFMD | N01045108 | 6/15/2021 | Close Meeting | Management | Yes | No | |
Acceleron Pharma Inc. | XLRN | 00434H108 | 6/16/2021 | Elect Director Habib J. Dable | Management | Yes | For | No |
Acceleron Pharma Inc. | XLRN | 00434H108 | 6/16/2021 | Elect Director Terrence C. Kearney | Management | Yes | For | No |
Acceleron Pharma Inc. | XLRN | 00434H108 | 6/16/2021 | Elect Director Karen L. Smith | Management | Yes | For | No |
Acceleron Pharma Inc. | XLRN | 00434H108 | 6/16/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Acceleron Pharma Inc. | XLRN | 00434H108 | 6/16/2021 | Advisory Vote on Say on Pay Frequency | Management | Yes | One Year | No |
Acceleron Pharma Inc. | XLRN | 00434H108 | 6/16/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Grand Canyon Education, Inc. | LOPE | 38526M106 | 6/16/2021 | Elect Director Brian E. Mueller | Management | Yes | For | No |
Grand Canyon Education, Inc. | LOPE | 38526M106 | 6/16/2021 | Elect Director Sara R. Dial | Management | Yes | For | No |
Grand Canyon Education, Inc. | LOPE | 38526M106 | 6/16/2021 | Elect Director Jack A. Henry | Management | Yes | For | No |
Grand Canyon Education, Inc. | LOPE | 38526M106 | 6/16/2021 | Elect Director Lisa Graham Keegan | Management | Yes | For | No |
Grand Canyon Education, Inc. | LOPE | 38526M106 | 6/16/2021 | Elect Director Chevy Humphrey | Management | Yes | For | No |
Grand Canyon Education, Inc. | LOPE | 38526M106 | 6/16/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Grand Canyon Education, Inc. | LOPE | 38526M106 | 6/16/2021 | Ratify KPMG LLP as Auditors | Management | Yes | For | No |
Nautilus, Inc. | NLS | 63910B102 | 6/16/2021 | Elect Director James 'Jim' Barr, IV | Management | Yes | For | No |
Nautilus, Inc. | NLS | 63910B102 | 6/16/2021 | Elect Director Richard A. Horn | Management | Yes | For | No |
Nautilus, Inc. | NLS | 63910B102 | 6/16/2021 | Elect Director M. Carl Johnson, III | Management | Yes | For | No |
Nautilus, Inc. | NLS | 63910B102 | 6/16/2021 | Elect Director Patricia 'Patty' M. Ross | Management | Yes | For | No |
Nautilus, Inc. | NLS | 63910B102 | 6/16/2021 | Elect Director Anne G. Saunders | Management | Yes | For | No |
Nautilus, Inc. | NLS | 63910B102 | 6/16/2021 | Elect Director Marvin G. Siegert | Management | Yes | For | No |
Nautilus, Inc. | NLS | 63910B102 | 6/16/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Nautilus, Inc. | NLS | 63910B102 | 6/16/2021 | Ratify Grant Thornton LLP as Auditors | Management | Yes | For | No |
ShotSpotter, Inc. | SSTI | 82536T107 | 6/16/2021 | Elect Director William J. Bratton | Management | Yes | Withhold | Yes |
ShotSpotter, Inc. | SSTI | 82536T107 | 6/16/2021 | Elect Director Deborah A. Elam | Management | Yes | For | No |
ShotSpotter, Inc. | SSTI | 82536T107 | 6/16/2021 | Elect Director Randall Hawks, Jr. | Management | Yes | Withhold | Yes |
ShotSpotter, Inc. | SSTI | 82536T107 | 6/16/2021 | Ratify Baker Tilly US, LLP as Auditors | Management | Yes | For | No |
908 Devices, Inc. | MASS | 65443P102 | 6/17/2021 | Elect Director Fenel M. Eloi | Management | Yes | For | No |
908 Devices, Inc. | MASS | 65443P102 | 6/17/2021 | Elect Director Jeffrey P. George | Management | Yes | For | No |
908 Devices, Inc. | MASS | 65443P102 | 6/17/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
Aerie Pharmaceuticals, Inc. | AERI | 00771V108 | 6/17/2021 | Elect Director Mechiel (Michael) M. du Toit | Management | Yes | For | No |
Aerie Pharmaceuticals, Inc. | AERI | 00771V108 | 6/17/2021 | Elect Director David W. Gryska | Management | Yes | For | No |
Aerie Pharmaceuticals, Inc. | AERI | 00771V108 | 6/17/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
Aerie Pharmaceuticals, Inc. | AERI | 00771V108 | 6/17/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | Against | Yes |
Frequency Therapeutics, Inc. | FREQ | 35803L108 | 6/17/2021 | Elect Director Cynthia L. Feldmann | Management | Yes | For | No |
Frequency Therapeutics, Inc. | FREQ | 35803L108 | 6/17/2021 | Elect Director Michael Huang | Management | Yes | Withhold | Yes |
Frequency Therapeutics, Inc. | FREQ | 35803L108 | 6/17/2021 | Elect Director Joel S. Marcus | Management | Yes | Withhold | Yes |
Frequency Therapeutics, Inc. | FREQ | 35803L108 | 6/17/2021 | Ratify RSM US LLP as Auditors | Management | Yes | For | No |
Autolus Therapeutics Plc | AUTL | 05280R100 | 6/18/2021 | Accept Financial Statements and Statutory Reports | Management | Yes | For | No |
Autolus Therapeutics Plc | AUTL | 05280R100 | 6/18/2021 | Approve Remuneration Report | Management | Yes | For | No |
Autolus Therapeutics Plc | AUTL | 05280R100 | 6/18/2021 | Reappoint Ernst & Young LLP as Auditors and Authorise Their Remuneration | Management | Yes | For | No |
Autolus Therapeutics Plc | AUTL | 05280R100 | 6/18/2021 | Elect Director Linda Bain | Management | Yes | For | No |
Autolus Therapeutics Plc | AUTL | 05280R100 | 6/18/2021 | Elect Director Cynthia Butitta | Management | Yes | For | No |
Autolus Therapeutics Plc | AUTL | 05280R100 | 6/18/2021 | Elect Director Christian Itin | Management | Yes | For | No |
BioLife Solutions, Inc. | BLFS | 09062W204 | 6/18/2021 | Elect Director Michael Rice | Management | Yes | For | No |
BioLife Solutions, Inc. | BLFS | 09062W204 | 6/18/2021 | Elect Director Raymond W. Cohen | Management | Yes | For | No |
BioLife Solutions, Inc. | BLFS | 09062W204 | 6/18/2021 | Elect Director Andrew Hinson | Management | Yes | For | No |
BioLife Solutions, Inc. | BLFS | 09062W204 | 6/18/2021 | Elect Director Joseph Schick | Management | Yes | For | No |
BioLife Solutions, Inc. | BLFS | 09062W204 | 6/18/2021 | Elect Director Amy DuRoss | Management | Yes | For | No |
BioLife Solutions, Inc. | BLFS | 09062W204 | 6/18/2021 | Elect Director Rachel Ellingson | Management | Yes | For | No |
BioLife Solutions, Inc. | BLFS | 09062W204 | 6/18/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
BioLife Solutions, Inc. | BLFS | 09062W204 | 6/18/2021 | Amend Omnibus Stock Plan | Management | Yes | For | No |
Jounce Therapeutics, Inc. | JNCE | 481116101 | 6/18/2021 | Elect Director J. Duncan Higgons | Management | Yes | Withhold | Yes |
Jounce Therapeutics, Inc. | JNCE | 481116101 | 6/18/2021 | Elect Director Robert Iannone | Management | Yes | Withhold | Yes |
Jounce Therapeutics, Inc. | JNCE | 481116101 | 6/18/2021 | Elect Director Luisa Salter-Cid | Management | Yes | For | No |
Jounce Therapeutics, Inc. | JNCE | 481116101 | 6/18/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Kindred Biosciences, Inc. | KIN | 494577109 | 6/22/2021 | Elect Director Raymond Townsend | Management | Yes | Against | Yes |
Kindred Biosciences, Inc. | KIN | 494577109 | 6/22/2021 | Elect Director Ervin Veszpremi | Management | Yes | Against | Yes |
Kindred Biosciences, Inc. | KIN | 494577109 | 6/22/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Kindred Biosciences, Inc. | KIN | 494577109 | 6/22/2021 | Ratify KMJ Corbin & Company LLP as Auditors | Management | Yes | For | No |
Vapotherm, Inc. | VAPO | 922107107 | 6/22/2021 | Elect Director Lori Knowles | Management | Yes | For | No |
Vapotherm, Inc. | VAPO | 922107107 | 6/22/2021 | Elect Director Mary Beth Moynihan | Management | Yes | For | No |
Vapotherm, Inc. | VAPO | 922107107 | 6/22/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Vapotherm, Inc. | VAPO | 922107107 | 6/22/2021 | Advisory Vote on Say on Pay Frequency | Management | Yes | One Year | No |
Vapotherm, Inc. | VAPO | 922107107 | 6/22/2021 | Ratify Grant Thornton LLP as Auditors | Management | Yes | For | No |
Intellia Therapeutics, Inc. | NTLA | 45826J105 | 6/23/2021 | Elect Director Fred Cohen | Management | Yes | Withhold | Yes |
Intellia Therapeutics, Inc. | NTLA | 45826J105 | 6/23/2021 | Elect Director Jean-Francois Formela | Management | Yes | Withhold | Yes |
Intellia Therapeutics, Inc. | NTLA | 45826J105 | 6/23/2021 | Elect Director Frank Verwiel | Management | Yes | Withhold | Yes |
Intellia Therapeutics, Inc. | NTLA | 45826J105 | 6/23/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
Intellia Therapeutics, Inc. | NTLA | 45826J105 | 6/23/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Bright Horizons Family Solutions Inc. | BFAM | 109194100 | 6/24/2021 | Elect Director Julie Atkinson | Management | Yes | For | No |
Bright Horizons Family Solutions Inc. | BFAM | 109194100 | 6/24/2021 | Elect Director Jordan Hitch | Management | Yes | For | No |
Bright Horizons Family Solutions Inc. | BFAM | 109194100 | 6/24/2021 | Elect Director Laurel J. Richie | Management | Yes | For | No |
Bright Horizons Family Solutions Inc. | BFAM | 109194100 | 6/24/2021 | Elect Director Mary Ann Tocio | Management | Yes | For | No |
Bright Horizons Family Solutions Inc. | BFAM | 109194100 | 6/24/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Bright Horizons Family Solutions Inc. | BFAM | 109194100 | 6/24/2021 | Advisory Vote on Say on Pay Frequency | Management | Yes | One Year | No |
Bright Horizons Family Solutions Inc. | BFAM | 109194100 | 6/24/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
Flexion Therapeutics, Inc. | FLXN | 33938J106 | 6/24/2021 | Elect Director Michael D. Clayman | Management | Yes | Withhold | Yes |
Flexion Therapeutics, Inc. | FLXN | 33938J106 | 6/24/2021 | Elect Director Elizabeth Kwo | Management | Yes | For | No |
Flexion Therapeutics, Inc. | FLXN | 33938J106 | 6/24/2021 | Elect Director Ann Merrifield | Management | Yes | Withhold | Yes |
Flexion Therapeutics, Inc. | FLXN | 33938J106 | 6/24/2021 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | Yes | For | No |
Flexion Therapeutics, Inc. | FLXN | 33938J106 | 6/24/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Robert Selander | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Jon Kessler | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Stephen Neeleman | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Frank Corvino | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Adrian Dillon | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Evelyn Dilsaver | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Debra McCowan | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Stuart Parker | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Ian Sacks | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Elect Director Gayle Wellborn | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Ratify PricewaterhouseCoopers LLP as Auditor | Management | Yes | For | No |
HealthEquity, Inc. | HQY | 42226A107 | 6/24/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Quanterix Corporation | QTRX | 74766Q101 | 6/24/2021 | Elect Director Martin D. Madaus | Management | Yes | Withhold | Yes |
Quanterix Corporation | QTRX | 74766Q101 | 6/24/2021 | Elect Director Laurie J. Olson | Management | Yes | For | No |
Quanterix Corporation | QTRX | 74766Q101 | 6/24/2021 | Ratify Ernst & Young LLP as Auditors | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Elect Director Bassil I. Dahiyat | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Elect Director Ellen G. Feigal | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Elect Director Kevin C. Gorman | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Elect Director Kurt A. Gustafson | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Elect Director Yujiro S. Hata | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Elect Director A. Bruce Montgomery | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Elect Director Richard J. Ranieri | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Elect Director Dagmar Rosa-Bjorkeson | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Ratify RSM US LLP as Auditors | Management | Yes | For | No |
Xencor, Inc. | XNCR | 98401F105 | 6/24/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
Magnite, Inc. | MGNI | 55955D100 | 6/28/2021 | Elect Director Robert J. Frankenberg | Management | Yes | For | No |
Magnite, Inc. | MGNI | 55955D100 | 6/28/2021 | Elect Director Sarah P. Harden | Management | Yes | For | No |
Magnite, Inc. | MGNI | 55955D100 | 6/28/2021 | Elect Director James Rossman | Management | Yes | For | No |
Magnite, Inc. | MGNI | 55955D100 | 6/28/2021 | Ratify Deloitte & Touche LLP as Auditors | Management | Yes | For | No |
Magnite, Inc. | MGNI | 55955D100 | 6/28/2021 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | Yes | For | No |
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant | Destra Investment Trust |
By (Signature and Title)* | /s/ Robert Watson | |
Robert Watson, President | ||
(principal executive officer) |
Date | August 20, 2021 |
* Print the name and title of each signing officer under his or her signature.